In contrast, atorvastatin administration in NASH mice induced ileum mRNA expression of Nr0b2/Shp and Fgf15, which are major targets of the FXR nuclear receptor for BA, as compared with untreated vehicle NASH controls. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatohepatitis.